Reimbursement
The following sections will assist healthcare professionals and payers by providing appropriate coding and billing information associated with the treatment of pancreatic cancer. Read More ›
Discussions of site-neutrality reimbursement for oncology services have centered on flawed comparisons of Medicare reimbursement methodologies that would deprive patients of the best available care, according to the American Society of Clinical Oncology (ASCO) policy statement. Read More ›
As the trend of shifting the site of infusion services from the physician office to the hospital outpatient department continues, so does the conversation about the revenue differences in doing so. Clearly, there can be substantial differentials; however, it is interesting that the largest differences stem from payer contracts. Read More ›
